Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 October 2024 | Story Anthony Mthembu | Photo Supplied
Prof Tameshnie Deane
Prof Tameshnie Deane, Vice-Dean: Research, Postgraduate Studies and Internationalisation in the Faculty of Law at the University of the Free State (UFS).

The Faculty of Law at the University of the Free State (UFS) has appointed Prof Tameshnie Deane as Vice-Dean: Research, Postgraduate Studies and Internationalisation. Prof Deane officially assumed this role on 1 July 2024, following over two decades as a Professor and Head of the Criminal Law Unit at the University of South Africa (UNISA).

Prof Deane, who has approached this new position with great enthusiasm, describes it as a significant opportunity. ‘’This role allows me to influence the future of academic research and postgraduate education at UFS,’’ she said.

Support for postgraduate students

Prof Deane elaborated on her vision, saying, “My aim is to develop and implement strategies that elevate the quality and impact of research, foster innovation, and support postgraduate students in achieving their academic and professional goals.”

Among her top priorities is strengthening support for postgraduate students at the UFS. “I plan to introduce comprehensive mentorship programmes where experienced faculty members guide students through their academic and research journeys. We will offer training in key skills such as legal writing, research methodologies, and public speaking, while also prioritising initiatives to support their mental and emotional well-being,’’ she explained.

Prof Deane emphasised that creating a dynamic and supportive environment will contribute to academic excellence and personal growth for postgraduate students at the UFS.

Enhancing internationalisation and strategic collaborations

Prof Deane is also committed to advancing the internationalisation of the Faculty of Law.  “We aim to provide opportunities for international collaboration and exchange, which will broaden the scope and impact of our research and postgraduate programmes,’’ she said.

Improving research quality and output remains a core objective, with Prof Deane identifying this as central to her new role.

One of the initiatives Prof Deane is eager to lead is the development of strategic partnerships with industry and academic institutions. “Collaborations like these will provide invaluable resources for research projects,” she noted.

To foster these partnerships, Prof Deane plans to leverage technology to strengthen communication and collaboration, support relationship-building events, and promote interdisciplinary projects that encourage diverse perspectives and innovative solutions. 

News Archive

#Women'sMonth: Save the children
2017-08-10

Description: Trudi O'Neill Tags: : rotaviruses, young children, Dr Trudi O’Neill, Department of Microbial, Biochemical and Food Biotechnology, vaccine 

Dr Trudi O’Neill, Senior lecturer in the Department of
Microbial, Biochemical and Food Biotechnology.
Photo: Anja Aucamp

Dr Trudi O’Neill, Senior lecturer in the Department of Microbial, Biochemical and Food Biotechnology, is conducting research on rotavirus vaccines.

Dr O’Neill was inspired to conduct research on this issue through her fascination with the virus. “The biology of rotaviruses, especially the genome structure and the virus’ interaction with the host, is fascinating.”

“In fact, it is estimated that, globally, ALL children will be infected with rotavirus before the age of five, irrespective of their socio-economic standing. However, infants and young children in poor countries are more vulnerable due to inadequate healthcare. The WHO estimates that approximately 215 000 deaths occur each year. This roughly equates to eight Airbus A380 planes, the largest commercial carrier with a capacity of approximately 500 seats, filled with only children under the age of five, crashing each week of every year.”

Alternative to expensive medicines 
“Currently, there are two vaccines that have been licensed for global use. However, these vaccines are expensive and poor countries, where the need is the greatest, are struggling to introduce them sustainably. It is therefore appealing to study rotaviruses, as it is scientifically challenging, but could at the same time have an impact on child health,” Dr O’Neill said.

The main focus of Dr O’Neill’s research is to develop a more affordable vaccine that can promote child vaccination in countries/areas that cannot afford the current vaccines.

All about a different approach 

When asked about the most profound finding of her research, Dr O’Neill responded: “It is not so much a finding, but rather the approach. My rotavirus research group is making use of yeast as vehicle to produce a sub-unit vaccine. These microbes are attractive, as they are relatively easy to manipulate and cheap to cultivate. Downstream production costs can therefore be reduced. The system we use was developed by my colleagues, Profs Koos Albertyn and Martie Smit, and allows for the potential use of any yeast. This enables us to screen a vast number of yeasts in order to identify the best yeast producer.”

Vaccination recently acquired a bad name in the media for its adverse side effects. As researcher, Dr O’Neill has this to say: “Vaccines save lives. By vaccinating your child, you don’t just protect your own child from a potentially deadly infection, but also other children in your community that might be too young to be vaccinated or have pre-existing health problems that prevents vaccination.” 

A future without rotavirus vaccination?

Dr O’Neill believes a future without rotavirus vaccination will be a major step backwards, as the impact of rotavirus vaccines has been profound. “Studies in Mexico and Malawi actually show a reduction in deaths. A colleague in Mozambique has commented on the empty hospital beds that amazed both clinicians and scientists only one year after the introduction of the vaccine in that country. Although many parents, mostly in developed countries, don’t have to fear dehydrating diarrhoea and potential hospitalisation of their babies due to rotavirus infection anymore, such an infection could still be a death sentence in countries that have not been able to introduce the vaccine in their national vaccination programmes,” she said. 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept